Department of Emergency Medicine, CHR Orléans, Orléans, Francia.
Tours University, School of Medicine, and Tours University Hospital, Emergency Medicine Department, Tours, Francia.
Emergencias. 2020 Feb;32(1):19-25.
Correctly identifying patients with acute coronary syndrome (ACS) on first contact is essential, yet emergency dispatchers currently lack a risk scale that can help predict an ACS diagnosis. Our main aim was to develop and validate such a risk scale.
Prospective, observational single-center study in 2016 (January 1 to December 31). We included patients who called our emergency dispatch center to report nontraumatic chest pain. Included patients were randomly assigned to a development or a validation sample. The predictive SCARE scale was built with logistic regression analysis. Discrimination and calibration were analyzed by calculating the area under the receiver operating characteristic curve; calibration was assessed with the Hosmer-Lemeshow test.
The development sample included 902 patients. The regression model identified 7 variables associated with a final diagnosis of ACS: male sex, age, smoking, typical pain characteristics, first episode of chest pain, diaphoresis, and physician intuition (the teledispatcher's suspicion). When we applied the scale in the validation sample of 465 patients the area under the curve was 0.81 (95% CI, 0.76-0.87). The Hosmer-Lemeshow statistic was 5.18 (P=.74).
The SCARE scale had good discrimination and calibration properties. The scale should be further validated in an external sample from a multicenter study before it is implemented by emergency dispatch centers.
在首次接触时正确识别急性冠状动脉综合征(ACS)患者至关重要,但目前的紧急调度员缺乏能够帮助预测 ACS 诊断的风险量表。我们的主要目的是开发和验证这样的风险量表。
这是一项 2016 年(1 月 1 日至 12 月 31 日)进行的前瞻性、观察性单中心研究。我们纳入了向我们的紧急调度中心报告非创伤性胸痛的患者。纳入的患者被随机分配到开发或验证样本中。使用逻辑回归分析构建预测性 SCARE 量表。通过计算接受者操作特征曲线下的面积来分析判别和校准;通过 Hosmer-Lemeshow 检验评估校准。
开发样本包括 902 名患者。回归模型确定了与 ACS 最终诊断相关的 7 个变量:男性、年龄、吸烟、典型疼痛特征、胸痛首次发作、出汗和医生直觉(远程调度员的怀疑)。当我们在 465 名验证样本中应用该量表时,曲线下面积为 0.81(95%CI,0.76-0.87)。Hosmer-Lemeshow 统计量为 5.18(P=.74)。
SCARE 量表具有良好的判别和校准性能。在实施前,该量表应在来自多中心研究的外部样本中进一步验证。